Search

Home > Lung Cancer Considered > LAURA Study (Part 2) - Radiation Oncology Perspective
Podcast: Lung Cancer Considered
Episode:

LAURA Study (Part 2) - Radiation Oncology Perspective
Category: Science & Medicine
Duration: 00:47:21
Publish Date: 2025-02-04 18:20:07
Description: This episode of Lung Cancer Considered covers the recent FDA approval of Osimertinib after chemo-radiation in EGFR positive NSCLC based on the LAURA trial which was presented at the 2024 ASCO Annual Meeting. Host Dr. Narjust Florez goes in depth with podcast guest Dr. Pamela Samson about the LAURA Trial and its implications for patients and clinicians. Guest: Dr. Pamela Samson is an assistant professor in the Department of Radiation Oncology at Washington University in St. Louis. Dr. Samson specializes in the care of thoracic malignancies and ways to deliver appropriate radiation therapy without compromising efficacy and diminishing toxicities.
Total Play: 0